Parametric Portfolio Associates’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$254K Sell
366
-82
-18% -$63.3K ﹤0.01% 3342
2021
Q4
$405K Buy
448
+28
+7% +$26.6K ﹤0.01% 3148
2021
Q3
$423K Buy
420
+198
+89% +$146K ﹤0.01% 3175
2021
Q2
$144K Sell
222
-131
-37% -$90.9K ﹤0.01% 3456
2021
Q1
$261K Buy
353
+157
+80% +$127K ﹤0.01% 3771
2020
Q4
$152K Buy
196
+9
+5% +$7.09K ﹤0.01% 3836
2020
Q3
$185K Sell
187
-11
-6% -$11.7K ﹤0.01% 3682
2020
Q2
$205K Buy
198
+55
+38% +$55.3K ﹤0.01% 3623
2020
Q1
$116K Buy
+143
New +$149K ﹤0.01% 3690

Other funds holding GOSS

Parametric Portfolio Associates's GOSS Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Gossamer Bio (GOSS) stake by 18% in Q1 2022, selling an estimated $63.3K and leaving 366 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #3342.

Parametric Portfolio Associates first reported a position in GOSS in Q1 2020 and has held it in 9 quarters since. The position peaked at $423K in Q3 2021. 139 funds tracked by Wall St. Rank hold GOSS as of Q1 2022.

  • Parametric Portfolio Associates held 366 shares of Gossamer Bio worth $254K as of Q1 2022.
  • Parametric Portfolio Associates sold 82 Gossamer Bio shares in Q1 2022, an estimated $63.3K.
  • Gossamer Bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3342 holding.
  • Parametric Portfolio Associates first reported a position in Gossamer Bio in Q1 2020 and has held it in 9 quarters since.
  • Parametric Portfolio Associates's Gossamer Bio position peaked at $423K in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.